Peter A. Nagi

Peter Nagi practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Peter Nagi's NPI, 1124079058, was assigned on May 15, 2006. Peter Nagi graduated from University of Alabama School of Medicine in 1999. Peter Nagi holds Alabama license 23678.

Peter Nagi's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Peter Nagi's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Peter Nagi is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Peter Nagi practices. Vendor and product names are available with a free account.

Anesthesiology is Peter Nagi's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Peter Nagi is licensed in Alabama.

CMS data shows 715 Medicare services from Peter Nagi across 8 procedure codes in 2024, for 306 Medicare patients. Medicare paid $40,272 for them.

CMS counts 306 Medicare patients who saw Peter Nagi in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have arthritis, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Peter Nagi's median patient age at 63, with 67% women.

In 2024, Peter Nagi wrote 668 Medicare Part D claims for 215 patients. 96% of them were for generic drugs. CMS names the drug for 622 of them, across 8 drugs with 11 or more claims each, at $25,917 in total drug cost. In 2023, CMS named 324 claims across 7 drugs.

Peter Nagi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Peter Nagi as offering telehealth.

Dmand AI links 4 papers to Peter Nagi, published from 2019 to 2024. Peter Nagi has published most often in Cureus. Peter Nagi's most frequent co-authors are Promil Kukreja, Hanna Hussey, MD and Scott Ervin Mabry, MD.

Dmand AI links Peter Nagi to 1 clinical trial. Conditions studied include Sleep Apnea, Obstructive and Sleep Apnea Syndromes.

CMS Open Payments shows 63 general payments to Peter Nagi from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Pacira Pharmaceuticals Incorporated paid the most, $598.

Peter Nagi graduated from University of Alabama School of Medicine in 1999.